Skip to main content
Have a personal or library account? Click to login
Forecasting the effect of water gastric emptying patterns on model drug release in an in vitro glass-bead flow-through system Cover

Forecasting the effect of water gastric emptying patterns on model drug release in an in vitro glass-bead flow-through system

Open Access
|May 2024

References

  1. D. M. Mudie, G. L. Amidon and G. E. Amidon, Physiological parameters for oral delivery and in vitro testing, Mol. Pharmaceutics 7(5) (2010) 1388–1405; https://doi.org/10.1021/mp100149j
  2. Z. Vinarov, M. Abdallah, J. A. G. Agundez, K. Allegaert, A. W. Basit, M. Braeckmans, J. Ceulemans, M. Corsetti, B. T. Griffin, M. Grimm, D. Keszthelyi, M. Koziolek, C. M. Madla, C. Matthys, L. E. Mc-Coubrey, A. Mitra, C. Reppas, J. Stappaerts, N. Steenackers, N. L. Trevaskis, T. Vanuytsel, M. Vertzoni, W. Weitschies, C. Wilson and P. Augustijns, Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review, Eur. J. Pharm. Sci. 162 (2021) Article ID 105812 (33 pages); https://doi.org/10.1016/j.ejps.2021.105812
  3. A. Y. Abuhelwa, D. J. R. Foster and R. N. Upton, A quantitative review and meta-models of the variability and factors affecting oral drug absorption-Part I: Gastrointestinal pH, AAPS J. 18(5) (2016) 1309–1321; https://doi.org/10.1208/s12248-016-9952-8
  4. J. Fallingborg, L. A. Christensen, M. Ingeman-Nielsen, B. A. Jacobsen, K. Abildgaard and H. H. Rasmussen, pH-Profile and regional transit times of the normal gut measured by radiotelemetry device, Aliment. Pharmacol. Ther. 3(6) (1989) 605–613; https://doi.org/10.1111/j.1365-2036.1989.tb00254.x
  5. A. Lindahl, A.-L. Ungell, L. Knutson and H. Lennernäs, Characterization of fluids from the stomach and proximal jejunum in men and women, Pharm. Res. 14(4) (1997) 497–502; https://doi.org/10.1023/A:1012107801889
  6. M. Koziolek, M. Grimm, D. Becker, V. Iordanov, H. Zou, J. Shimizu, C. Wanke, G. Garbacz and W. Weitschies, Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap((R)) system, J. Pharm. Sci. 104(9) (2015) 2855–2863; https://doi.org/10.1002/jps.24274
  7. T. L. Russell, R. R. Berardi, J. L. Barnett, L. C. Dermentzoglou, K. M. Jarvenpaa, S. P. Schmaltz and J. B. Dressman, Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women, Pharm. Res. 10(2) (1993) 187–196; https://doi.org/10.1023/a:1018918316253
  8. M. Grimm, M. Koziolek, J. P. Kuhn and W. Weitschies, Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water, Eur. J. Pharm. Biopharm. 127 (2018) 309–317; https://doi.org/10.1016/j.ejpb.2018.03.002
  9. M. Grimm, E. Scholz, M. Koziolek, J. P. Kuhn and W. Weitschies, Gastric water emptying under fed state clinical trial conditions is as fast as under fasted conditions, Mol. Pharmaceutics 14(12) (2017) 4262–4271; https://doi.org/10.1021/acs.molpharmaceut.7b00623
  10. D. M. Mudie, K. Murray, C. L. Hoad, S. E. Pritchard, M. C. Garnett, G. L. Amidon, P. A. Gowland, R. C. Spiller, G. E. Amidon and L. Marciani, Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state, Mol. Pharmaceutics 11(9) (2014) 3039–3047; https://doi.org/10.1021/mp500210c
  11. C. Schiller, C. P. Frohlich, T. Giessmann, W. Siegmund, H. Monnikes, N. Hosten and W. Weitschies, Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging, Aliment. Pharmacol. Ther. 22(10) (2005) 971–979; https://doi.org/10.1111/j.1365-2036.2005.02683.x
  12. V. C. Ibekwe, H. M. Fadda, E. L. McConnell, M. K. Khela, D. F. Evans and A. W. Basit, Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileocolonic release systems, Pharm. Res. 25(8) (2008) 1828–1835; https://doi.org/10.1007/s11095-008-9580-9
  13. EMA. Guideline on investigation of bioequivalence, Committee for Medicinal Products for Human Use (CHMP), 2010.
  14. FDA. Guidance for industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations, U.S. Department of health and human services. Food and drug administration, Center for drug evaluation and research (CDER), 2002.
  15. M. Grimm, M. Koziolek, M. Saleh, F. Schneider, G. Garbacz, J. P. Kuhn and W. Weitschies, Gastric emptying and small bowel water content after administration of grapefruit juice compared to water and isocaloric solutions of glucose and fructose: A four-way crossover MRI pilot study in healthy subjects, Mol. Pharmaceutics 15(2) (2018) 548–559; https://doi.org/10.1021/acs.molpharmaceut.7b00919
  16. J. B. Leiper, Fate of ingested fluids: Factors affecting gastric emptying and intestinal absorption of beverages in humans, Nutr. Rev. 73 (Suppl 2) (2015) 57–72; https://doi.org/10.1093/nutrit/nuv032
  17. G. L. Amidon, A. DeBrincat and N. Najib, Effects of gravity on gastric emptying, intestinal transit, and drug absorption, J. Clin. Pharmacol. 31(10) (1991) 968–973; https://doi.org/10.1002/j.1552-4604.1991.tb03658.x
  18. R. L. Oberle, T. S. Chen, C. Lloyd, J. L. Barnett, C. Owyang, C. Meyer and G. L. Amidon. The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids, Gastroenterology 99(5) (1990) 1275–1282; https://doi.org/10.1016/0016-5085(90)91150-5
  19. H. A. Ziessman, A. Chander, J. O. Clarke, A. Ramos and R. L. Wahl, The added diagnostic value of liquid gastric emptying compared with solid emptying alone, J. Nucl. Med. 50(5) (2009) 726–731; https://doi.org/10.2967/jnumed.108.059790
  20. W. S. Nimmo, Drugs, diseases and altered gastric emptying, Clin. Pharmacokinet. 1(3) (1976) 189–203; https://doi.org/10.2165/00003088-197601030-00002
  21. N. Gainsborough, V. L. Maskrey, M. L. Nelson, J. Keating, R. A. Sherwood, S. H. D. Jackson and C. G. Swift, The association of age with gastric emptying, Age and Ageing 22(1) (1993) 37–40; https://doi.org/10.1093/ageing/22.1.37
  22. T. L. Russell, R. R. Berardi, J. L. Barnett, T. L. O’Sullivan, J. G. Wagner and J. B. Dressman, pH-related changes in the absorption of dipyridamole in the elderly, Pharm. Res. 11(1) (1994) 136–143.
  23. J. A. Clements, R. C. Heading, W. S. Nimmo and L. F. Prescott, Kinetics of acetaminophen absorption and gastric emptying in man, Clin. Pharmacol. Ther. 24(4) (1978) 420–431; https://doi.org/10.1002/cpt1978244420
  24. R. C. Heading, J. Nimmo, L. F. Prescott and P. Tothill, The dependence of paracetamol absorption on the rate of gastric emptying, Br. J. Pharm. 47(2) (1973) 415–421; 0.1111/j.1476-5381.1973.tb08339.x
  25. M. Willems, A. O. Quartero and M. E. Numans, How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study, Dig. Dis. Sci. 46(10) (2001) 2256–2262; https://doi.org/10.1023/a:1011935603893
  26. T. Sawamoto, S. Haruta, Y. Kurosaki, K. Higaki and T. Kimura, Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability, J. Pharm. Pharmacol. 49 (1997) 450–457; https://doi.org/10.1111/j.2042-7158.1997.tb06823.x
  27. A. M. Nader, S. K. Quinney, H. M. Fadda and D. R. Foster, Effect of gastric fluid volume on the in vitro dissolution and in vivo absorption of BCS class II drugs: A case study with nifedipine, AAPS J. 18(4) (2016) 981–988; https://doi.org/10.1208/s12248-016-9918-x
  28. B. Hens, Y. Tsume, M. Bermejo, P. Paixao, M. J. Koenigsknecht, J. R. Baker, W. L. Hasler, R. Lion-berger, J. Fan, J. Dickens, K. Shedden, B. Wen, J. Wysocki, R. Loebenberg, A. Lee, A. Frances, G. Amidon, A. Yu, G. Benninghoff, N. Salehi, A. Talattof, D. Sun and G. L. Amidon, Low buffer capacity and alternating motility along the human gastrointestinal tract: Implications for in vivo dissolution and absorption of ionizable drugs, Mol. Pharmaceutics 14(12) (2017) 4281–4294; https://doi.org/10.1021/acs.molpharmaceut.7b00426
  29. R. L. Oberle and G. L. Amidon, The influence of variable gastric emptying and intestinal transit rates on plasma level curve of cimetidine; An explanation for the double peak phenomenon, J. Pharmacokinet. Biopharm. 15(5) (1987) 529–544; https://doi.org/10.1007/BF01061761
  30. M. Bogataj, G. Cof and A. Mrhar, Development of a glass-bead device for dissolution testing, Dissolution Technol. 22(3) (2015) 18–24; https://doi.org/10.14227/dt220315p18
  31. M. McAllister, Dynamic dissolution: A step closer to predictive dissolution testing?, Mol. Pharmaceutics 7(5) (2010) 1374–1387; https://doi.org/10.1021/mp1001203
  32. S. R. Carino, D. C. Sperry and M. Hawley, Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model, J. Pharm. Sci. 95(1) (2006) 116–125; https://doi.org/10.1002/jps.20495
  33. S. Takeuchi, Y. Tsume, G. E. Amidon and G. L. Amidon, Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution, J. Pharm. Sci. 103(11) (2014) 3416–3422; https://doi.org/10.1002/jps.24112
  34. C. R. Honigford, A. Aburub and H. M. Fadda, A simulated stomach duodenum model predicting the effect of fluid volume and prandial gastric flow patterns on nifedipine pharmacokinetics from cosolvent-based capsules, J. Pharm. Sci. 108(1) (2019) 288–294; https://doi.org/10.1016/j.xphs.2018.07.023
  35. K. Matsui, Y. Tsume, G. E. Amidon and G. L. Amidon, The evaluation of in vitro drug dissolution of commercially available oral dosage forms for itraconazole in gastrointestinal simulator with biorelevant media, J. Pharm. Sci. 105(9) (2016) 2804–2814; https://doi.org/10.1016/j.xphs.2016.02.020
  36. C. Jede, C. Wagner, H. Kubas, C. Weber, M. Weigandt, M. Koziolek and W. Weitschies, Automated small-scale in vitro transfer model as screening tool for the prediction of in vivo-dissolution and precipitation of poorly solubles, Int. J. Pharm. 556 (2019) 150–158; https://doi.org/10.1016/j.ijpharm.2018.12.013
  37. G. Garbacz, D. Cade, H. Benameur and W. Weitschies, Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus, Eur. J. Pharm. Sci. 57 (2014) 264–272; https://doi.org/10.1016/j.ejps.2013.08.039
  38. A. Ruff, T. Fiolka and E. S. Kostewicz, Prediction of ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling, Eur. J. Pharm. Sci. 100 (2017) 42–55; https://doi.org/10.1016/j.ejps.2016.12.017
  39. M. Sager, F. Schneider, P. Jedamzik, M. Wiedmann, E. Schremmer, M. Koziolek and W. Weitschies, Effect of coadministered water on the in vivo performance of oral formulations containing N-acetylcysteine: An in vitro approach using the dynamic open flow-through test apparatus, Mol. Pharmaceutics 14(12) (2017) 4272–4280; https://doi.org/10.1021/acs.molpharmaceut.7b00763
  40. H. Vrbanac, J. Trontelj, S. Berglez, B. Petek, J. Opara, R. Jereb, D. Krajcar and I. Legen, The biorelevant simulation of gastric emptying and its impact on model drug dissolution and absorption kinetics, Eur. J. Pharm. Biopharm. 149 (2020) 113–120; https://doi.org/10.1016/j.ejpb.2020.02.002
  41. G. Karamanolis, I. Theofanidou, M. Yiasemidou, E. Giannoulis, K. Triantafyllou and S. D. Ladas, A glass of water immediately increases gastric pH in healthy subjects, Dig. Dis. Sci. 53(12) (2008) 3128–3132; https://doi.org/10.1007/s10620-008-0301-3
  42. S. Yamashita, M. Kataoka, H. Higashino, S. Sakuma, T. Sakamoto, H. Uchimaru, H. Tsukikawa, M. Shiramoto, H. Uchiyama, H. Tachiki and S. Irie, Measurement of drug concentration in the stomach after intragastric administration of drug solution to healthy volunteers: Analysis of intragastric fluid dynamics and drug absorption, Pharm. Res. 30(4) (2013) 951–958; https://doi.org/10.1007/s11095-012-0931-1
  43. F. Schneider, M. Grimm, M. Koziolek, C. Modeß, A. Dokter, T. Roustom, W. Siegmund and W. Weitschies, Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state, Eur. J. Pharm. Biopharm. 108 (2016) 214–219; https://doi.org/10.1016/j.ejpb.2016.09.009
  44. S. H. Yalkowsky,Y. He and P. Jain, Handbook of Aqueous Solubility Data, 2nd ed., CRC Press, Boca Raton 2010.
  45. P. Zarmpi, T. Flanagan, E. Meehan, J. Mann and N. Fotaki, Biopharmaceutical understanding of excipient variability on drug apparent solubility based on drug physicochemical properties: Case study-hypromellose (HPMC), AAPS J. 22(2) (2020) Article ID 49 (15 pages); https://doi.org/10.1208/s12248-019-0411-1
  46. L. Kalantzi, C. Reppas, J. B. Dressman, G. L. Amidon, H. E. Junginger, K. K. Midha, V. P. Shah, S. A. Stavchansky and D. M. Barends, Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol), J. Pharm. Sci. 95(1) (2006) 4–14; https://doi.org/10.1002/jps.20477
  47. A. Chiarini, A. Tartarini and A. Fini, pH-Solubility relationship and partition coefficients for some anti-inflammatory arylaliphatic acids, Arc. Pharm. 317(3) (1984) 268–273.
  48. M. Kincl, M. Meleh, M. Veber and F. Vrečer, Study of physicochemical parameters affecting the release of diclofenac sodium from lipophilic matrix tablets, Acta Chim. Slov. 51(3) (2004) 409–425.
  49. T. Felicijan, M. Pišlar, K. Vene and M. Bogataj, The influence of simulated fasted gastrointestinal pH profiles on diclofenac sodium dissolution in a glass-bead flow-through system, AAPS PharmSciTech. 19(7) (2018) 2875–2884; https://doi.org/10.1208/s12249-018-1140-y
  50. J. Van Den Abeele, R. Schilderink, F. Schneider, R. Mols, M. Minekus, W. Weitschies, J. Brouwers, J. Tack and P. Augustijns, Gastrointestinal and systemic disposition of diclofenac under fasted and fed state conditions supporting the evaluation of in vitro predictive tools, Mol. Pharmaceutics 14(12) (2017) 4220–4232; https://doi.org/10.1021/acs.molpharmaceut.7b00253
  51. J. Van Den Abeele, J. Brouwers, R. Mattheus, J. Tack and P. Augustijns, Gastrointestinal behavior of weakly acidic BCS class II drugs in man-Case study of diclofenac potassium, J. Pharm. Sci. 105(2) (2016) 687–696; https://doi.org/10.1002/jps.24647
  52. I. Locatelli, A. Mrhar and M. Bogataj, Gastric emptying of pellets under fasting conditions: A mathematical model, Pharm. Res. 26(7) (2009) 1607–1617; https://doi.org/10.1007/s11095-009-9869-3
  53. M. Li, X. Zhang, D. Wu, O. Anand, H. Chen, K. Raines and L. Yu, Understanding in vivo dissolution of immediate release (IR) solid oral drug products containing weak acid BCS class 2 (BCS class 2a) drugs, AAPS J. 23(6) (2021) Article ID 113 (13 pages); https://doi.org/10.1208/s12248-021-00639-0
  54. J. H. Fagerberg, Y. Al-Tikriti, G. Ragnarsson and C. A. Bergstrom, Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid, Mol. Pharmaceutics 9(7) (2012) 1942–1952; https://doi.org/10.1021/mp2006467
DOI: https://doi.org/10.2478/acph-2024-0016 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 269 - 287
Accepted on: Feb 13, 2024
Published on: May 30, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2024 Tjaša Felicijan, Marija Bogataj, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.